Yahoo · Sep 28, 2026
Tulavi Therapeutics Awarded Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc.
Tulavi Therapeutics has been awarded a national group purchasing agreement and Breakthrough Technology Designation for Synthetic Implantable Products with Premier, Inc. Effective September 15, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the allay™ Hydrogel Cap, the first and only fully resorbable, in situ forming medical device indicated to reduce the risk of symptomatic neuroma formation. Premi

